Portfolio Update

RNS Number : 8815V

Intl. Biotechnology Trust PLC

17 July 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 30 June 2009                    

Total Net Assets	£90.5m
NAV per share	139.5p
Share Price	108.8p
Total value of unquoted investments	£20.3m
Total number of portfolio companies	60
Cash	4%
Cash committed and reserved to unquoted investments	13%
Portfolio companies with < 1 year of cash	15%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	7.8	7,083,876
Celgene	5.6	5,026,226
Amgen	4.9	4,444,090
Gilead Sciences	4.8	4,391,898
Alexion Pharmaceuticals	3.3	2,950,630
Wright Medical	3.2	2,854,507
EV3	3.0	2,725,803
Oxagen	2.7	2,412,057
Halozyme Therapeutics	2.6	2,367,984
Affymax	2.6	2,334,135
	-----------
Total	40.5	36,591,206

Geographical Allocation	%
United States	80
Europe	15
Cash	4
Australia	1
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	74
Unquoted	22
Cash	4
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

17 JULY 2009

 

END

 

 

PFUBDGDRBXBGGCR